logo
Select company
Select metric
$ -29.7MConsolidated Income
VS
Market
25
Sector
49
Industry
61
History
42
$ 8.59Close
$ 2.37 - $ 10.51 52-Week Range
Ticker Information

Ticker

CLNN

Company Name

CLENE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CLENE INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CLNN - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -29.7M
3/31/2025$ -29.07M
12/31/2024$ -39.4M
9/30/2024$ -36.02M
6/30/2024$ -30.46M
3/31/2024$ -48.81M
12/31/2023$ -49.5M
9/30/2023$ -40.38M
6/30/2023$ -48.94M
3/31/2023$ -28.33M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CLENE INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -36.47M.
  • Over the past 5 years, CLENE INC's average Cons. Inc. has been $ -29.67M.
  • The median Cons. Inc. for CLENE INC during this period was $ -30.19M
  • CLENE INC reached its highest Cons. Inc. over the past 5 years at $ 16.66M.
  • The lowest Cons. Inc. recorded by CLENE INC in the same timeframe $ -59.02M

CLENE INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
COEP : COEPTIS THERAPEUTICS HOLDINGS INC $ -12.6MABP : ABPRO HOLDINGS INC $ -12.3MPULM : PULMATRIX INC $ -7.93MIBIO : IBIO INC $ -18.38MCOCH : ENVOY MEDICAL INC $ -21.27MSABS : SAB BIOTHERAPEUTICS INC $ -37.06MHYPD : HYPERION DEFI INC $ -40.02MRPTX : REPARE THERAPEUTICS INC $ -109.86MSER : SERINA THERAPEUTICS INC $ -12.65MPMN : PROMIS NEUROSCIENCES INC $ -8.43M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

CLNN - Consolidated Income, Last 5 years

$ -59.02M

Minimum

Mar 31, 2021

$ 16.66M

Maximum

Mar 31, 2022

$ -29.67M

Average

$ -30.19M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.08M with a standard deviation of $ 116.5M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.08M
median$ -2.07M
std$ 116.5M